Chemically primed bone-marrow derived mesenchymal stem cells show enhanced expression of chemokine receptors contributed to their migration capability
- سال انتشار: 1395
- محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 19، شماره: 1
- کد COI اختصاصی: JR_IJBMS-19-1_002
- زبان مقاله: انگلیسی
- تعداد مشاهده: 416
نویسندگان
Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran
Shahroud University of Medical Sciences, Shahroud, Iran
Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran
Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran
Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran
Stem Cells and Regenerative Medicine Research Department, ACECR-Khorasan Razavi Branch, Mashhad, Iran
Stem Cells and Regenerative Medicine Research Department, ACECR-Khorasan Razavi Branch, Mashhad, Iran
Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran
Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran
چکیده
Objective(s):The limited homing potential of bone-marrow-derived mesenchymal stem cells (BM-MSC) is the key obstacle in MSC-based therapy. It is believed that chemokines and chemokine receptor interactions play key roles in cellular processes associated with migration. Meanwhile, MSCs express a low level of distinct chemokine receptors and they even lose these receptors on their surface after a few passages which influence their therapeutic applications negatively. This study investigated whether treatment of BM-MSCs with hypoxia-mimicking agents would increase expression of some chemokine receptors and cell migration. Materials and Methods: BM-MSCs were treated at passage ۲ for our gene expression profiling. All qPCR experiments were performed by SYBR Green method in CFX-۹۶ Bio-Rad Real-Time PCR. The Boyden chamber assay was utilized to investigate BM-MSC homing. Results:Possible approaches to increasing the expression level of chemokine receptors by different hypoxia-mimicking agents such as valproic acid (VPA), CoCl۲, and desferrioxamine (DFX) are described. Results show DFX efficiently up-regulate the CXCR۷ and CXCR۴ gene expression while VPA increase only the CXCR۷ gene expression and no significant change in expression level of CXCR۴ and the CXCR۷ gene was detectable by CoCl۲ treatment. Chemotaxis assay results show that pre-treatment with DFX, VPA, and Cocl۲ enhances significantly the migration ability of BM-MSCs compared with the untreated control group and DFX treatment accelerates MSCs homing significantly with a higher rate than VPA and Cocl۲ treatments. Conclusion: Our data supports the notion that pretreatment of MSC with VPA and DFX improves the efficiency of MSC therapy by triggering homing regulatory signaling pathways.کلیدواژه ها
CXCR۴, CXCR۷, CoCl۲, Desferrioxamine, MSC, Chemical treatment, Homing, Valproic acidاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.